Status:
COMPLETED
Insulin Dose Titration System Using a Short Messaging Service (SMS) Automatically Produced by a Knowledge Matrix
Lead Sponsor:
Hallym University Medical Center
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The investigators designed the system in type 2 diabetic patients treated with long acting insulin to produce an automatic adjustment of insulin dose based on real time glucose level data and to provi...
Detailed Description
Most patients with type 2 diabetes will, in time, need insulin therapy. Starting insulin poses considerable challenges. Also, improving glycemic control with insulin therapy often requires periodic do...
Eligibility Criteria
Inclusion
- patients with type 2 diabetes suboptimally controlled on their previous antidiabetic treatment were included
- age ≥ 18 years
- on antidiabetic treatment (any oral and/or insulin therapy) for \> 6 months
- A1C levels \> 7.0 and \< 12.0%
- BMI values \< 35 kg/m2
Exclusion
- type 1 diabetes
- renal dysfunction (defined as creatinine blood level \> 2.0 mg/dL)
- hepatic dysfunction (defined as alanine aminotransferase and/or aspartate aminotransferase blood level \> 2.5 times the upper normal limit)
- hypoglycemic unawareness
- pregnancy
- severe retinopathy
- illiteracy
- elderly over than 70 yrs
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00948584
Start Date
November 1 2007
End Date
December 1 2008
Last Update
July 29 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.